News
GRAIL, Inc. was spun off from Illumina in 2024 and offers a promising multi-cancer early detection test called Galleri. Click ...
Zacks Investment Research on MSN4d
Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market ReachForTempus AI TEM, expanding partnerships with existing customers across each of its product lines is key to its growth. In April 2025, the AI-driven precision medicine company extended its ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), The Walt Disney Co ...
In a report released today, Kyle Mikson CFA from Canaccord Genuity maintained a Hold rating on Illumina (ILMN – Research Report), with a price target of $99.00. The company’s ...
Needham raised Lumentum Holdings Inc. LITE price target from $100 to $105. Needham analyst Ryan Koontz maintained a Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback